You have 9 free searches left this month | for more free features.

non-vasospastic subjects

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced NSCLC Trial in China (KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein

Enrolling by invitation
  • Advanced Non-small Cell Lung Cancer
  • KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein Injection)
  • Axitinib
  • Hefei, Anhui, China
  • +5 more
Oct 26, 2022

Non-radiographic Axial Spondyloarthritis Trial (SHR0302, SHR0302 )

Recruiting
  • Non-radiographic Axial Spondyloarthritis
  • Beijing, Beijing, China
    Beijing Hospital
Sep 1, 2022

Vulvovaginal Candidiasis, Candida Infection, Vaginal Candidiasis Trial in New Delhi (Non-interventional study)

Recruiting
  • Vulvovaginal Candidiasis
  • +2 more
  • Non-interventional study
  • New Delhi, Vasant Vihar, India
    AWINSA
Jun 8, 2023

B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

Recruiting
  • B-cell Non-Hodgkin Lymphoma (B-NHL)
  • UCART20x22
  • CLLS52
  • Austin, Texas
    Sarah Cannon - St. David South Austin Medical Center
Dec 8, 2022

Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)

Active, not recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Montclair, California
  • +12 more
Oct 11, 2022

Submental Fat Trial (RZL-012)

Not yet recruiting
  • Submental Fat
  • (no location specified)
Jul 17, 2022

Back Muscles With Low Back Pain Patients

Recruiting
  • Chronic Non-specific Low Back Pain
  • Ultrasonography imaging and Hand-held dynamometer (HHD)
  • Cairo, Egypt
    Cairo University
Oct 9, 2023

NSCLC Trial (KB-GDT-01)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • KB-GDT-01
  • (no location specified)
Sep 29, 2023

Advanced NSCLC Trial in Jilin (pemetrexed, Cetuximab, cis-platinum)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Jilin, Changchun, China
    Jilin Province Cancer Hospital
Aug 15, 2022

Non-Hodgkin Lymphoma Trial in BeiJing, Guangzhou, Shanghai (ZN-d5)

Enrolling by invitation
  • Non-Hodgkin Lymphoma
  • BeiJing, Beijing, China
  • +2 more
May 9, 2022

Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type DLBCL (ABC-DLBCL), Mantle Cell Lymphoma (MCL) Trial in Indianapolis, Spokane

Recruiting
  • Non-Hodgkin's Lymphoma (NHL)
  • +4 more
  • Indianapolis, Indiana
  • +1 more
Jul 12, 2022

Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC), Systemic Sclerosis (SSc) Trial in Tel Aviv (CM-101,

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • +2 more
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Sep 7, 2023

Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Port Saint Lucie, Florida
  • +1 more
Aug 11, 2023

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +4 more
  • (no location specified)
Oct 23, 2023

NSCLC, Non-Small Cell Lung Adenocarcinoma, Non-Small Cell Squamous Lung Cancer Trial in Grand Rapids, San Antonio, Fairfax

Recruiting
  • Non-small Cell Lung Cancer
  • +10 more
  • Grand Rapids, Michigan
  • +2 more
Apr 25, 2023

Obstructive Pulmonary Function, Restrictive Pulmonary Function Trial in Winter Park, Baltimore, Berlin (single dose (100 mg) of

Not yet recruiting
  • Obstructive Pulmonary Function
  • Restrictive Pulmonary Function
  • single dose (100 mg) of ASA
  • single dose (162 mg) of non-enteric-coated chewable aspirin tablets
  • Winter Park, Florida
  • +2 more
Nov 21, 2022

Atrial Fibrillation Trial in Tbilisi (Left Atrial Appendage Closure)

Recruiting
  • Atrial Fibrillation
  • Left Atrial Appendage Closure
  • Tbilisi, Georgia
    Tbilisi Heart and Vascular Clinic
Sep 29, 2022

Cardiac Output Measurements, Healthy Subjects Trial in Leuven (Pulsify sensor, State-of-the-art ultrasound equipment)

Completed
  • Cardiac Output Measurements
  • Healthy Subjects
  • Pulsify sensor
  • State-of-the-art ultrasound equipment
  • Leuven, Vlaams-Brabant, Belgium
    UZ Leuven
Feb 8, 2023

Advanced NSCLC Trial (SHR-A1811 & Pyrotinib/SHR-A1811 & SHR-1316)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer
  • SHR-A1811 & Pyrotinib/SHR-A1811 & SHR-1316
  • (no location specified)
Jul 29, 2022

Hypercholesterolemia Trial (HSK31679 low dose, HSK31679 medium dose, HSK31679 high dose)

Not yet recruiting
  • Hypercholesterolemia
  • HSK31679 low dose
  • +4 more
  • (no location specified)
Mar 20, 2023

Liver Fat, Liver Fibrosis, Glycemic Control Trial (Ertugliflozin 5 mg, 15mg)

Not yet recruiting
  • Liver Fat
  • +5 more
  • Ertugliflozin 5 mg, 15mg
  • (no location specified)
Nov 30, 2022

Breast Cancer, Nonsmall Cell Lung Cancer Trial in Beijing ([14C]GB491)

Completed
  • Breast Cancer
  • Nonsmall Cell Lung Cancer
  • Beijing, Beijing, China
    Beijing GoBroad Boren Hospital
May 5, 2023

Hepatic Impairment Trial (DZD9008)

Not yet recruiting
  • Hepatic Impairment
  • (no location specified)
Oct 10, 2023

NSCLC Trial in Cologne (observational, non-interventional)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • observational, non-interventional
  • Cologne, Germany
    University Hospital Cologne
Jul 3, 2023

Advanced Solid Tumor Trial in Guangzhou (NWY001)

Not yet recruiting
  • Advanced Solid Tumor
  • NWY001
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Cancer
Aug 6, 2023